Eric Campeau
![Eric Campeau Eric Campeau](https://afdd-summit.com/wp-content/uploads/sites/130/2024/07/Eric-Campeau-150x150.jpg)
Company: Thryv Therapeutics
Job title: Vice President Translational Research
Seminars:
Developing Novel Small Molecule Inhibitors of Serum & Glucocorticoid Regulated Kinase 1 (SGK1) for the Treatment of Fibrotic Diseases 3:00 pm
SGK1 is involved in the integration of pro-fibrotic signalling through the TGFb, PI3K, and MAPK pathways Inhibiting SGK1 decreases expression of several fibrotic markers in vitro and in vivo Leveraging how SGK1 inhibition offers a novel approach to address several pro-fibrotic pathways simultaneouslyRead more
day: Day Two